Claims for Patent: 11,957,832
✉ Email this page to a colleague
Summary for Patent: 11,957,832
| Title: | Breath actuated inhaler |
| Abstract: | A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes. |
| Inventor(s): | Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson |
| Assignee: | Norton Waterford Ltd |
| Application Number: | US17/062,185 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,957,832 |
| Patent Claims: |
1. A valve port for a pneumatic force holding unit in a breath actuated metered dose inhaler, said valve port comprising: a valve seal surface configured to be sealably engaged by a movable valve seal, wherein the valve seal surface has a surface roughness average (RA) of less than about 0.15 μm; and an annular boss with an inner wall defining a valve orifice channel wherein: a volume of the valve orifice channel is greater than about 12.7% of a volume of the annular boss; or the inner wall defines a frustum of an imaginary cone with an apex angle of greater than about 20 degrees. 2. The valve port of claim 1, wherein the valve seal comprises an elastomer. 3. The valve port of claim 2, wherein the valve seal comprises a thermoplastic elastomer. 4. The valve port of claim 2, wherein the elastomer has a hardness of from about 80 to 90 Shore A. 5. The valve port of claim 1, wherein the valve port is injection molded. 6. The valve port of claim 5, comprising: one or more radially outwardly extending projections defining a path through which polymer passes to form the annular boss during injection molding. 7. The valve port of claim 6, wherein the one or more radially outwardly extending projections comprises at least two radially outwardly extending projections and the at least two radially outwardly extending projections are substantially uniformly circumferentially separated, wherein the annular boss has a longitudinal axis which passes through the valve orifice channel, and wherein the at least two radially outwardly extending projections and the valve orifice channel lie in a common plane coincident with the longitudinal axis. 8. The valve port of claim 7, further comprising: a canister fire system including a flap valve, wherein the flap valve comprises: a chassis for pivotal mounting within the inhaler; a valve port seal mounted on the chassis configured to selectively engage the valve port in a sealing relation; and a vane for moving the valve port seal away from the valve port in response to inhalation induced airflow. 9. The valve port of claim 6, wherein an upper surface of the one or more radially outwardly extending projections and an upper surface of the annular boss are contiguous. 10. The valve port of claim 9, wherein the upper surface of the annular boss and the upper surface of the one or more radially outwardly extending projections are at an angle between about 90 degrees and about 180 degrees. 11. The valve port of claim 10, wherein the angle is obtuse. 12. The valve port of claim 6, wherein the valve port is located on a planar body and a portion of the planar body immediately adjacent the annular boss has a depth that is less than or equal to a thickness of the one or more radially outwardly extending projections, and wherein the portion of the planar body immediately adjacent the annular boss circumferentially surrounds the annular boss between the one or more radially extending projections. 13. The valve port of claim 1, wherein the valve port comprises acrylonitrile butadiene styrene. 14. The valve port of claim 1, wherein the apex angle is within a range of about 22 degrees to about 35 degrees. 15. The valve port of claim 1, further comprising at least one of: a diaphragm for a pneumatic force holding unit in a canister fire mechanism of a breath actuated metered dose inhaler; and a flap valve comprising: a chassis for pivotal mounting within the inhaler; a valve port seal mounted on the chassis configured to selectively engage the valve port in a sealing relation; and a vane for moving the valve port seal away from the valve port in response to inhalation induced airflow, wherein the diaphragm comprises a rigid disk portion and flexible membrane, and wherein the valve port is unitarily formed with the rigid disk portion. 16. A breath actuated metered dose inhaler comprising a pneumatic force holding unit, wherein the pneumatic force holding unit comprises a valve port in accordance with claim 1. 17. The breath actuated metered dose inhaler of claim 16, wherein the valve port is injection molded. 18. The valve port of claim 1, wherein the breath actuated metered dose inhaler includes a canister containing a mixture of an active drug and a propellant. 19. The valve port of claim 18, wherein the active drug is selected from the group consisting of beclomethasone dipropionate (BDP), salbutamol sulphate, and dihydroergotamine. 20. The valve port of claim 18, wherein the active drug is for treatment or prevention of a respiratory disease. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
